Clinical Trials

BreastDermatologicGastrointestinalGenitourinaryGynecologicOther hematologic neoplasmPlasma cellThoracic

1,600 enrolled

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Fallopian Tube Neoplasms, Lung Neoplasms, Melanoma, Multiple Myeloma, Ovarian Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Leukemia, Myeloid, Acute, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT07523789 2026-04-13

Comparison of Chemotherapy and Immunotherapy in Neoadjuvant Therapy for TNBC

Not yet recruiting

201 enrolled

Triple Negative Breast Neoplasms

NCT03586297 2026-03-27

Gut and Intratumoral Microbiome Effect on the Neoadjuvant Chemotherapy-induced Immunosurveillance in Triple Negative Breast Cancer

Completed

49 enrolled

Triple Negative Breast Neoplasms

NCT06396754 2026-03-27

AIDOBE

Not yet recruiting

50 enrolled

Triple Negative Breast Neoplasms

NCT04068623 2026-03-20

PERCEPTION

90 enrolled

Triple Negative Breast Neoplasms

NCT05404321 2026-03-19

TRIPLEX

163 enrolled

Triple Negative Breast Neoplasms

NCT05742269 2026-03-13

MIMIR-mTNBC

Terminated

3 enrolled

Triple Negative Breast Neoplasms

NCT07084571 2026-03-12

FORTITUDE

200 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06709651 2026-03-04

MINA

30 enrolled

Triple Negative Breast Neoplasms

NCT07211178 2026-03-04

GEMINI Breast

900 enrolled

Breast Neoplasms, Neoplasm, Residual, Triple Negative Breast Neoplasms

NCT07092254 2026-02-20

Patterns of Care and Outcomes in Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer

760 enrolled

Triple Negative Breast Neoplasms

NCT07421479 2026-02-19

PDO-Mercurial

50 enrolled

Triple Negative Breast Neoplasms

NCT04981119 2026-02-13

BASECAMP-1